Tyra Biosciences, Inc. · NASDAQ:TYRA
Vestal Point Capital, LP's stake in Tyra Biosciences, Inc. fell to 4.50% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Vestal Point Capital, LP's stake in Tyra Biosciences, Inc. fell to 4.50%, 2,425,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 4.50%
- Shares
- 2,425,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 4.50% | 2,425,000 |
| Ryan Wilder | 4.50% | 2,425,000 |
Source
Related
- Tyra Biosciences, Inc.
- Vestal Point Capital, LP
- Tyra Biosciences, Inc. shareholders
- Schedule 13G · Vestal Point Capital, LP · May 15, 2025
- Schedule 13G · Bvf Partners L P · Sep 21, 2026
- Form 4 · Harris Todd · Sep 17, 2026
- Form 4 · Rueb Yuliya · Sep 17, 2026
- Form 4 · Fuhrman Alan · Sep 17, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 17, 2026